ALVESCO 160 INHALER 160mcg / dose pressurized inhalation solution medication leaflet

R03BA08 ciclesonide • Respiratory system | Other drugs for obstructive airway diseases, inhalants | Glucocorticoids

Ciclesonide is a glucocorticoid used for the treatment of asthma and allergic rhinitis. It works by reducing inflammation in the airways, alleviating symptoms such as breathing difficulties and nasal congestion.

The medication is administered as an inhaler or nasal spray, as directed by a doctor. It is important for patients to use the medication regularly to achieve maximum benefits.

Patients should be aware of potential side effects, such as throat irritation, hoarseness, or nasal dryness. It is important to inform the doctor of any unusual symptoms.

Common side effects include throat irritation, hoarseness, and nasal dryness. In rare cases, severe reactions such as oral fungal infections or allergic reactions may occur. Patients should be informed of these risks before starting treatment.

General data about ALVESCO 160 INHALER 160mcg / dose

Substance: ciclesonide

Date of last drug list: 10-04-2026

Commercial code: W64226001

Concentration: 160mcg / dose

Pharmaceutical form: pressurized inhalation solution

Quantity: 1

Product type: original

Price: 94.72 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: TAKEDA GMBH - GERMANIA

Holder: ASTRAZENECA AB - SUEDIA

Number: 9031/2016/01

Shelf life: 3 years

Concentrations available for ciclesonide

160mcg/dose, 40mcg/dose, 80mcg/dose

Compensation lists for ALVESCO 160 INHALER 160mcg / dose ASTRAZENECA

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

94.72 RON

44.54 RON

50.19 RON